Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites

钙调神经磷酸酶-NFAT 调节转移前部位的内皮活化

基本信息

  • 批准号:
    9378981
  • 负责人:
  • 金额:
    $ 6.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Metastasis is responsible for most cancer-related mortality although it remains a poorly understood process. Metastatic tumor cells extravasate from the primary tumor and colonize in distant tissues with little understanding about mechanisms regulating colonization. The role of the vasculature in pre-metastatic sites and metastatic progression has not been extensively examined. Recent work from our lab shows that the calcineurin-NFAT pathway is activated specifically in lung endothelium prior to the detection of tumor cells that preferentially metastasize to the lung. Our preliminary data implicates endothelial activation as a prerequisite for metastatic colonization with this effect mediated at least partially via activation of the calcineurin-NFAT signaling pathway. Calcineurin, a ser/thr phosphatase, activates NFAT family transcription factors to regulate the development of many tissues. We and others have shown that the calcineurin-NFAT pathway is a key intracellular mediator of VEGF-A signaling in endothelial cells and angiogenesis. The importance of calcineurin signaling in tumor angiogenesis is illustrated by the remarkable protection against solid tumors observed in Down syndrome (DS) individuals. Our previously published studies in a Down syndrome mouse model indicate that defects in tumor angiogenesis resulting in significantly decreased tumor growth is due in part to attenuation of calcineurin signaling in endothelial cell by the increased expression of chromosome 21-encoded inhibitors of this pathway, Down syndrome candidate region-1 (Dscr1) and Dual specificity kinase 1A (Dyrk1A). Here we propose to explore novel clinically relevant roles for this signaling pathway and two specific downstream targets, thrombospondin-1 (TSP-1) and angiopoietin-2 (ANG-2) in activating the vascular endothelium in pre-metastatic sites in the lung and liver. We hypothesize that endothelial activation primes pre-metastatic sites providing a receptive microenvironment for the engraftment and survival of metastatic tumor cells. We will genetically and pharmacologically manipulate the calcineurin-NFAT pathway, TSP-1 and ANG-2 expression in endothelial cells to determine the effects on lung and liver metastasis. We will utilize transgenic mouse models of primary tumors that spontaneously metastasize to the lung or liver as well as lung and liver colonization assays to investigate metastatic tumor cell engraftment. Our studies will better elucidate the biology of calcineurin-NFAT-TSP-1 and ANG-2 signaling in endothelial cells at metastatic sites and mechanisms underlying metastatic tumor cell colonization in distant tissues. These findings may also lead to new therapies to prevent widespread lung and liver metastasis.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sandra Ryeom其他文献

Sandra Ryeom的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sandra Ryeom', 18)}}的其他基金

The role of endothelial cells in the formation of early metastatic niches in the lung
内皮细胞在肺早期转移灶形成中的作用
  • 批准号:
    10241023
  • 财政年份:
    2021
  • 资助金额:
    $ 6.94万
  • 项目类别:
The role of endothelial cells in the formation of early metastatic niches in the lung
内皮细胞在肺早期转移灶形成中的作用
  • 批准号:
    10570116
  • 财政年份:
    2021
  • 资助金额:
    $ 6.94万
  • 项目类别:
Negative Regulation of VEGF-Mediated Angiogenesis
VEGF 介导的血管生成的负调控
  • 批准号:
    7901792
  • 财政年份:
    2009
  • 资助金额:
    $ 6.94万
  • 项目类别:
Negative Regulation of VEGF-Mediated Angiogenesis
VEGF 介导的血管生成的负调控
  • 批准号:
    8073963
  • 财政年份:
    2009
  • 资助金额:
    $ 6.94万
  • 项目类别:
Negative Regulation of VEGF-Mediated Angiogenesis
VEGF 介导的血管生成的负调控
  • 批准号:
    7652961
  • 财政年份:
    2009
  • 资助金额:
    $ 6.94万
  • 项目类别:
Negative Regulation of VEGF-Mediated Angiogenesis
VEGF 介导的血管生成的负调节
  • 批准号:
    7778284
  • 财政年份:
    2009
  • 资助金额:
    $ 6.94万
  • 项目类别:
Negative Regulation of VEGF-Mediated Angiogenesis
VEGF 介导的血管生成的负调节
  • 批准号:
    8248591
  • 财政年份:
    2009
  • 资助金额:
    $ 6.94万
  • 项目类别:
Negative Regulation of VEGF-Mediated Angiogenesis
VEGF 介导的血管生成的负调节
  • 批准号:
    8462223
  • 财政年份:
    2009
  • 资助金额:
    $ 6.94万
  • 项目类别:
Project 4 - Characterizing and Overcoming Resistance to ERBB2 Directed Therapy in Metastatic Gastric and Esophageal Adenocarcinoma
项目 4 - 描述和克服转移性胃癌和食管腺癌对 ERBB2 定向治疗的耐药性
  • 批准号:
    10456161
  • 财政年份:
    2007
  • 资助金额:
    $ 6.94万
  • 项目类别:
Z0 1 SIGNALING IN CORNEAL EPITHELIAL CELL BIOLOGY
角膜上皮细胞生物学中的 Z0 1 信号传导
  • 批准号:
    6087578
  • 财政年份:
    1999
  • 资助金额:
    $ 6.94万
  • 项目类别:

相似海外基金

Development of Novel Lung Cancer Therapy Using Tumor-Specific Angiogenesis Inhibitors and Drug Repositioning
使用肿瘤特异性血管生成抑制剂和药物重新定位开发新型肺癌疗法
  • 批准号:
    21H03019
  • 财政年份:
    2021
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of biomarkers related to drug resistance of angiogenesis inhibitors
血管生成抑制剂耐药性相关生物标志物的开发
  • 批准号:
    20K08542
  • 财政年份:
    2020
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural and Functional Studies of Brain Angiogenesis Inhibitors (BAIs/ADGRBs)
脑血管生成抑制剂 (BAIs/ADGRB) 的结构和功能研究
  • 批准号:
    9813883
  • 财政年份:
    2019
  • 资助金额:
    $ 6.94万
  • 项目类别:
Elucidation of proteinuria expression mechanism by angiogenesis inhibitors and research on adverse effect avoidance
血管生成抑制剂蛋白尿表达机制的阐明及不良反应避免的研究
  • 批准号:
    17K08457
  • 财政年份:
    2017
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of cardiotoxicity and elucidation of cardiotoxic molecular mechanisms in cancer patients receiving angiogenesis inhibitors
接受血管生成抑制剂的癌症患者的心脏毒性评估和心脏毒性分子机制的阐明
  • 批准号:
    26461102
  • 财政年份:
    2014
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Minimally invasive response evaluation in vivo for the dual therapy of the angiogenesis inhibitors
血管生成抑制剂双重治疗的体内微创疗效评价
  • 批准号:
    23591763
  • 财政年份:
    2011
  • 资助金额:
    $ 6.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANGIOGENESIS INHIBITORS IN THE MULTIMODAL TREATMENT OF PEDIATRIC SOLID TUMORS
血管生成抑制剂在小儿实体瘤多模式治疗中的应用
  • 批准号:
    8309814
  • 财政年份:
    2011
  • 资助金额:
    $ 6.94万
  • 项目类别:
Discovery and Investigation of Novel Angiogenesis Inhibitors Among Existing Drugs
现有药物中新型血管生成抑制剂的发现和研究
  • 批准号:
    7351352
  • 财政年份:
    2008
  • 资助金额:
    $ 6.94万
  • 项目类别:
Discovery and Investigation of Novel Angiogenesis Inhibitors Among Existing Drugs
现有药物中新型血管生成抑制剂的发现和研究
  • 批准号:
    8002099
  • 财政年份:
    2008
  • 资助金额:
    $ 6.94万
  • 项目类别:
Discovery and Investigation of Novel Angiogenesis Inhibitors Among Existing Drugs
现有药物中新型血管生成抑制剂的发现和研究
  • 批准号:
    7537218
  • 财政年份:
    2008
  • 资助金额:
    $ 6.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了